The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies
Hannah M. Hicks(University of Colorado Denver), Rebecca E. Schweppe(University of Colorado Cancer Center)
Cited by 7
Related Papers
Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid Cancer
|The Journal of Clinical Endocrinology & Metabolism|2009|65
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma
|Molecular Cancer Therapeutics|2021|37